![](https://i0.wp.com/www.weeklyblitz.net/wp-content/uploads/2021/10/COVID-cases-in-Indian-Uttar-Pradesh-drops-by-97.1-percent-because-of-Ivermectin-use.jpg?fit=900%2C607&ssl=1)
The effectiveness of ivermectin is determined by dose.
Let's use the anti-malaria drug Malarone as an example. For prevention purpose, the dose is one pill per day. But if the patient contracts the virus, the treatment requires a much higher dose. Dose matters.
Similarily, the prevention, early treatment, and late treatment of COVID using ivermectin require different doses, ranging from 0.2mg/KG to 0.6mg/KG. Such protocol was made based on clinical experience by frontline doctors at FLCCC.net.
There are already several ivermectin trials published on the CDC/FDA websites. However, all those trials used much lower doses than the FLCCC protocol. Therefore, the results were not satisfying. CDC/FDA use it as an excuse to prevent the use of ivermectin for COVID.
So, it's not about whether there is a trial, but about whether the trial makes sense by using effective doses.